Updated results from the KATHERINE trial showed that adjuvant T-DM1 provided a significant improvement in overall survival and no evidence of long-term safety issues.

Per- and polyfluoroalkyl substances (PFAS) in drinking water is associated with cancer incidence, a new study suggests.

(HealthDay News) — The US Centers for Disease Control and Prevention (CDC) recently confirmed another case of avian influenza A (H5N1), or bird flu, in a person in California, bringing the nationwide ...

Caroline Wagner is a professor of public affairs at The Ohio State University. She receives funding from SECURE, a research security service funded by the National Science Foundat ...

The FDA has approved Calquence (acalabrutinib) for use in combination with bendamustine and rituximab to treat adults with previously untreated MCL who are ineligible for transplant.

Monica M. Bertagnolli, MD, has decided to resign her post as director of the NIH just 14 months after she took the position.

Source: Getty Images Updated results from the ASC4FIRST trial support the use of asciminib as standard care for patients with newly diagnosed, Ph+ CP-CML, according to Jorge E. Cortes, MD.

Source: Getty Images Global concern about research security is growing. Governments are worried about international rivals gaining military or trade advantages or security secrets via cross-border ...

The FDA has revoked the authorization for the use of FD&C Red No. 3 in food and ingested drugs due to evidence suggesting this dye can cause cancer in rats.

Hormone therapy does not appear to increase the risk of glioma among women in the United States, data suggest.